Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.
You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.
Other companies in Avalo Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
Avalo Therapeutics has a consensus price target of $12.92.
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $13.24 last updated November 12, 2024 at 4:06 PM EST.
There are no upcoming dividends for Avalo Therapeutics.
Avalo Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Avalo Therapeutics.
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.